Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Vitale

Showing results (121-130 of 219) with videos related to

Pageof 22
Sort By:
Ocular Immunology and Inflammation|November 4, 2017
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related UveitisClaudia Fabiani, Jurgen Sota, Antonio Vitale, et al.
Clinical Rheumatology|April 4, 2018
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitisClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
The British Journal of Ophthalmology|August 28, 2017
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up studyClaudia Fabiani, Jurgen Sota, Antonio Vitale, et al.
Journal of Autoimmunity|April 24, 2026
PPAR-γ dysregulation links NF-κB activation and Nrf2-driven antioxidant responses in axial spondyloarthritis: A pilot studyGiuseppe Lopalco, Giuseppe Carota, Nicolò Musso, et al.
Clinical Rheumatology|November 18, 2016
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational studyClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
Clinical Rheumatology|June 24, 2014
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in ItalyLuca Cantarini, Antonio Vitale, Orso Maria Lucherini, et al.
Clinical Rheumatology|April 20, 2018
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumabClaudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Mediators of Inflammation|March 19, 2019
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective StudyAlice Bitossi, Alessandra Bettiol, Elena Silvestri, et al.
Journal of Ultrasound|October 13, 2022
Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experienceSuhel G Al Khayyat, Giuseppe Fogliame, Stefano Barbagli, et al.
Scientific Reports|June 15, 2021
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profilePiero Ruscitti, Antonio Barile, Onorina Berardicurti, et al.
Pageof 22

Showing results (121-130 of 219) with videos related to

Sort By:
Pageof 22
Ocular Immunology and Inflammation|November 4, 2017
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related UveitisClaudia Fabiani, Jurgen Sota, Antonio Vitale, et al.
Clinical Rheumatology|April 4, 2018
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitisClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
The British Journal of Ophthalmology|August 28, 2017
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up studyClaudia Fabiani, Jurgen Sota, Antonio Vitale, et al.
Journal of Autoimmunity|April 24, 2026
PPAR-γ dysregulation links NF-κB activation and Nrf2-driven antioxidant responses in axial spondyloarthritis: A pilot studyGiuseppe Lopalco, Giuseppe Carota, Nicolò Musso, et al.
Clinical Rheumatology|November 18, 2016
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational studyClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
Clinical Rheumatology|June 24, 2014
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in ItalyLuca Cantarini, Antonio Vitale, Orso Maria Lucherini, et al.
Clinical Rheumatology|April 20, 2018
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumabClaudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Mediators of Inflammation|March 19, 2019
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective StudyAlice Bitossi, Alessandra Bettiol, Elena Silvestri, et al.
Journal of Ultrasound|October 13, 2022
Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experienceSuhel G Al Khayyat, Giuseppe Fogliame, Stefano Barbagli, et al.
Scientific Reports|June 15, 2021
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profilePiero Ruscitti, Antonio Barile, Onorina Berardicurti, et al.
Pageof 22